← All published screens
Highest ROE in Healthcare
Snapshot from 2026-10-02 · 25 stocks
Sector is Healthcare
| Ticker | Name | Sector | Price | Market Cap | P/E | P/B | ROE | Gross Margin |
|---|---|---|---|---|---|---|---|---|
| MTD | Mettler-Toledo International Inc. | Healthcare | $1,481.17 | $29.68B | 34.14 | 2314.40 | 6778.4% | — |
| HALO | Halozyme Therapeutics, Inc. - Common Stock | Healthcare | $106.94 | $12.14B | 38.30 | 84.56 | 220.8% | — |
| AMRX | Amneal Pharmaceuticals, Inc. - Class A Common Stock | Healthcare | $20.07 | $6.41B | 88.95 | 194.08 | 218.2% | — |
| RIGL | Rigel Pharmaceuticals, Inc. | Healthcare | $46.97 | $877.39M | 2.39 | 2.06 | 86.3% | — |
| AVAH | Aveanna Healthcare Holdings Inc. | Healthcare | $12.43 | $2.71B | 12.05 | 9.44 | 78.3% | — |
| GILD | Gilead Sciences, Inc. - Common Stock | Healthcare | $147.50 | $182.89B | 21.49 | 15.46 | 71.9% | — |
| COR | Cencora, Inc. | Healthcare | $309.78 | $59.11B | 38.04 | 19.38 | 50.9% | — |
| THC | Tenet Healthcare Corporation | Healthcare | $253.97 | $20.45B | 8.64 | 4.39 | 50.8% | — |
| AUPH | Aurinia Pharmaceuticals Inc - Common Shares | Healthcare | $15.95 | $2.12B | 7.39 | 3.45 | 46.7% | — |
| EXEL | Exelixis, Inc. - Common Stock | Healthcare | $57.94 | $14.36B | 18.35 | 7.79 | 42.4% | — |
| ZVRA | Zevra Therapeutics, Inc. | Healthcare | $10.18 | $604.53M | 7.26 | 2.78 | 38.2% | — |
| CHE | Chemed Corporation | Healthcare | $502.90 | $6.57B | 24.78 | 7.91 | 31.9% | — |
| DXCM | DexCom, Inc. | Healthcare | $86.23 | $32.54B | 38.91 | 12.41 | 31.9% | — |
| BMY | Bristol-Myers Squibb Company | Healthcare | $61.46 | $125.55B | 17.80 | 5.63 | 31.6% | — |
| JNJ | Johnson & Johnson | Healthcare | $258.66 | $623.34B | 23.26 | 7.34 | 31.5% | — |
| NVS | Novartis AG Common Stock | Healthcare | $141.05 | $269.14B | 19.25 | 5.83 | 30.3% | — |
| ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | $19.89 | $3.43B | 8.77 | 2.62 | 29.9% | — |
| PAHC | Phibro Animal Health Corporation - Class A Common Stock | Healthcare | $35.87 | $2.47B | 24.79 | 6.41 | 25.9% | — |
| RMD | ResMed Inc. Common Stock | Healthcare | $221.15 | $31.90B | 20.94 | 4.84 | 23.1% | — |
| MDXG | MiMedx Group, Inc. | Healthcare | $4.64 | $676.33M | 13.92 | 3.13 | 22.5% | — |
| PBYI | Puma Biotechnology, Inc. | Healthcare | $9.84 | $507.94M | 16.33 | 3.67 | 22.5% | — |
| CPRX | Catalyst Pharmaceuticals, Inc. | Healthcare | $31.49 | $3.85B | 17.98 | 3.81 | 21.2% | — |
| OGN | Organon & Co. Common Stock | Healthcare | $13.71 | $3.60B | 19.25 | 3.58 | 18.6% | — |
| SALR.LJ | Salus | Healthcare | $70.50 | $579.46M | 34.16 | 6.27 | 18.3% | — |
| TEVA | Teva Pharmaceutical Industries Limited Ordinary Shares | Healthcare | $39.31 | $45.81B | 32.49 | 5.91 | 18.2% | — |